Twelve-Month Action Checklist for the Moroccan Medical Device Market

1. Key takeaways

The typical cycle for a manufacturer from the Chinese mainland entering Morocco is 12 months, progressing through seven phases. Months 1–2: secure the license-holding establishment and complete product classification. Months 2–5: establishment declaration (Article 7) with its 90-day deemed acceptance (Article 8), with dossier preparation running in parallel. Months 5–6: checklist self-check and submission. Months 6–10: review (statutory ceiling of 120 days) and completeness corrections. Months 10–12: obtaining the certificate, importing and the first post-market compliance actions. The registration certificate is valid for 5 years, with a renewal reminder set 6 months ahead (the cycle ranges are a practical estimate). The plan below turns that outline into sequenced actions, on the principle that the decisions made in month one determine how much of the remaining eleven months is spent building or repairing. Each phase is anchored to a specific statutory mechanism, so slippage can be diagnosed quickly: if the schedule drifts, the cause is usually visible in the phase whose statutory clock is not running.

2. Legal basis

Practical estimate note: the 12-month total cycle and the seven-phase time splits are GRZAN scheduling advice based on the statutory deadlines (90 days plus 120 days) and consistent industry practice; they are not an official commitment.

3. Expert insights

Insight 1: the most important task of month one is not paperwork but the entity. Paragraph 2 of Article 12 requires the license-holding establishment to be a declared establishment in Morocco, and Article 17 requires a transfer authorization to change certificate holders. Choosing the wrong partner in month one means correction costs that run through the entire year. This is why the plan puts “securing the license-holding establishment” first, ahead of every document task. The screening criteria are concrete: the establishment must already be declared, its declared activities must match the intended role, and its willingness to cooperate on a future transfer should be tested before signing.

Insight 2: the 90-day establishment declaration window and the dossier preparation period can overlap. The 90-day deemed-acceptance window of Article 8 does not need to be waited out idle. A sound schedule is: start the establishment declaration in month 2, prepare the product dossier in parallel in months 2–5, and reach the expiry of the 90 days and the completion of the dossier at the same time in month 5.

Insight 3: 120 days is a ceiling, and completeness corrections do not count inside it. The review period of Article 4 of Décret No. 2-14-607 starts from the submission of a complete dossier. The checklist self-check in months 5–6 is the key act protecting that clock — one successful submission beats three rounds of chasing.

Insight 4: three obligations fall due immediately after the certificate is issued. The 48-hour vigilance reporting of Article 25, the continuous clinical data evaluation and change notification of Article 16, and the recall and disposal readiness of Article 29. These three must be built before the certificate arrives, not improvised after an event occurs. The certificate issue date is the wrong time to design a vigilance workflow, since the first reportable event may occur within days of first sale, and the 48-hour window leaves no room for building process from scratch.

Insight 5: two 2026 rules should be scheduled in advance. Second-hand and refurbished devices (Decision No. 630-26, March 2026) require a two-stage path with the new device registered first; maintenance spare parts (DE RD DM/10, July 3, 2026) require a separate authorization valid for 2 years. If neither is planned in the first year, both will surface during the after-sales phase.

4. Practical recommendations

1. Month 1: fix the entity. Screen the AMMPS directory for declared establishments whose activities include “import”, verify the legal representative and signature process, and sign an agreement containing a transfer-cooperation clause under Article 17.
2. Months 1–2: fix the classification. Determine the class under the five criteria of Article 4, cross-check against the CE certificate, and produce a classification note.
3. Month 2: start the establishment declaration. File under the current checklist (DE RD-IS-PS/04), keep the receipt, and start the 90-day clock.
4. Months 2–5: prepare the dossier in parallel. Assemble evidence by class tier (CE/FSC/ISO 13485); the manufacturer produces the technical documents, the license-holding establishment produces the administrative documents, each signed and stamped page by page.
5. Months 5–6: checklist self-check and submission. Cross-check the dossier item by item against the current AMMPS checklist (DE ER DM/01), confirm the payment receipts are complete, then submit.
6. Months 6–10: review and corrections. Track the progress of the advisory committee (Article 36) and respond to completeness requests within the shortest time.
7. Months 10–12: certificate and post-market readiness. After the certificate is issued, complete the import undertaking and customs clearance; bring the vigilance workflow, change classification table, recall plan and renewal ledger live at the same time.

5. Verification checklist

• □ Month 1: the license-holding establishment is secured and the agreement contains an Article 17 transfer-cooperation clause
• □ Months 1–2: the class has been determined under Article 4 and cross-checked against the CE certificate
• □ Month 2: the establishment declaration has been filed under DE RD-IS-PS/04 with the receipt retained
• □ Months 2–5: the administrative dossier documents are each dated, signed and stamped
• □ Months 2–5: the evidence documents (CE/FSC/ISO 13485) are complete according to the class tier
• □ Months 5–6: the dossier has been cross-checked item by item against DE ER DM/01 and the fees paid
• □ Months 6–10: review progress is tracked and the correction-response mechanism is in place
• □ Months 10–12: the registration certificate has been obtained and the import undertaking and clearance completed
• □ Months 10–12: the 48-hour vigilance workflow, change classification table and recall plan are live
• □ Months 10–12: the renewal reminder is set 6 months ahead of the 5-year expiry
• □ Throughout: second-hand/refurbished (630-26) and spare-parts authorization (DE RD DM/10) are scheduled as needed

Regulatory information verified as of October 30, 2026

Post-market support from GRZAN. GRZAN provides post-market compliance support for medical device manufacturers and importers serving the Moroccan market, covering materiovigilance reporting, recall and withdrawal execution, and inspection and enforcement response, alongside market-entry planning such as the twelve-month roadmap above. If you need the plan adapted to your product portfolio, contact info@grzanglobal.com.